# EU MDR Technical File Template

**Regulatory Reference**: EU MDR 2017/745 Annex II and Annex III
**Template Version**: 1.0.0
**Last Updated**: 2025-02-09
**Valid For**: Class I, IIa, IIb, and III Medical Devices

---

## Technical File Information

| Field | Value |
|-------|-------|
| **Device Name** | [Enter device name] |
| **Manufacturer** | [Enter manufacturer name] |
| **Device Classification** | [Class I/IIa/IIb/III] |
| **Device Group** | [Enter device group if applicable] |
| **Technical File Version** | [Enter version number] |
| **Date of Issue** | [Enter date] |
| **Authorized Representative** | [Enter name if applicable] |
| **Notified Body** | [Enter NB number if applicable] |

---

## Document Control

### Revision History

| Version | Date | Changes | Approved By |
|---------|------|---------|-------------|
| 1.0 | [Date] | Initial technical file | [Name] |

### Document List

This Technical File consists of the following documents:

| Section | Document | Reference | Location |
|---------|----------|-----------|----------|
| 1 | Device Description | TF-1.1 | [Location] |
| 2 | Labelling and IFU | TF-2.1 | [Location] |
| 3 | General Safety and Performance Requirements | TF-3.1 | [Location] |
| 4 | Benefit-Risk Analysis | TF-4.1 | [Location] |
| 5 | Clinical Evaluation | TF-5.1 | [Location] |
| 6 | Post-Market Surveillance | TF-6.1 | [Location] |
| 7 | Risk Management | TF-7.1 | [Location] |
| 8 | Design Verification and Validation | TF-8.1 | [Location] |
| 9 | Manufacturing Processes | TF-9.1 | [Location] |
| 10 | Biological Safety | TF-10.1 | [Location] |
| 11 | Sterilization (if applicable) | TF-11.1 | [Location] |
| 12 | Biocompatibility (if applicable) | TF-12.1 | [Location] |
| 13 | Essential Principles Checklists | TF-13.1 | [Location] |

---

## Annex II: Technical Documentation

### Section 1: Device Description and Specifications

#### 1.1 Device Identification

**Device Name**: [Enter device name]

**Trade Name(s)**: [Enter trade names]

**Device Model(s)**: [Enter model numbers]

**Device Intended Purpose**: [Describe intended purpose]

**Intended Use**: [Describe intended use]

**Indications for Use**: [List indications]

**Contraindications**: [List contraindications]

#### 1.2 Device Classification

**Classification Rule**: [Specify MDR Rule number]

**Classification Rationale**: [Explain why device is classified as stated]

**Device Class**: [Class I/IIa/IIb/III]

**Is device a Group of Devices**: [Yes/No]
- If Yes, describe device group and justification

#### 1.3 Device Description

**General Description**: [Provide comprehensive device description]

**Device Variants**: [Describe all variants]

**Accessories**: [List accessories and their status]

**Parts and Materials**: [List key parts and materials]

#### 1.4 Specifications

**Technical Specifications**:

| Specification | Value | Range/Tolerance |
|---------------|-------|-----------------|
| [Specification 1] | [Value] | [Tolerance] |
| [Specification 2] | [Value] | [Tolerance] |
| [Specification 3] | [Value] | [Tolerance] |

**Performance Specifications**:

| Performance Parameter | Value | Test Method |
|----------------------|-------|-------------|
| [Parameter 1] | [Value] | [Method] |
| [Parameter 2] | [Value] | [Method] |

---

### Section 2: Labelling, Instructions for Use, and Packaging

#### 2.1 Labelling

**Primary Label Content**:

- [ ] Device name and trade name
- [ ] Manufacturer details
- [ ] Batch/Lot code
- [ ] Sterilization method (if applicable)
- [ ] Sterile/Non-sterile status
- [ ] Single use/Reusable
- [ ] UDI carrier (UDI-DI and UDI-PI)
- [ ] Storage conditions
- [ ] Intended user
- [ ] Instructions for use reference
- [ ] Warnings and precautions
- [ ] Year of manufacture
- [ ] "Do not reuse if sterile" (if applicable)
- [ ] "Single use only" (if applicable)

**Label Copy**: [Attach actual label copy]

**UDI Assignment**:

**UDI-DI**: [Enter UDI-DI]

**UDI Issuing Agency**: [GS1, HIBCC, ICCBBA, IFA]

**UDI Carrier Formats**:
- [ ] UDI-DI in Human Readable Interpretation (HRI)
- [ ] UDI-PI in HRI
- [ ] UDI in AIDC (Automatic Identification and Data Capture)

#### 2.2 Instructions for Use (IFU)

**IFU Language**: [Languages provided]

**IFU Content Checklist**:

- [ ] Intended purpose
- [ ] Indications for use
- [ ] Contraindications
- [ ] Warnings and precautions
- [ ] Adverse events
- [ ] Device description
- [ ] Operation instructions
- [ ] Maintenance instructions
- [ ] Reuse instructions (if reusable)
- [ ] Disposal instructions
- [ ] Manufacturer details
- [ ] Declaration of conformity reference

**IFU Copy**: [Attach IFU]

#### 2.3 Packaging

**Primary Packaging**: [Describe]

**Secondary Packaging**: [Describe]

**Transport Packaging**: [Describe]

**Packaging Validation**: [Reference validation report]

---

### Section 3: General Safety and Performance Requirements (GSPRs)

#### 3.1 GSPR Compliance Matrix

| MDR Annex I GSPR | Compliance Status | Evidence Reference |
|-----------------|-------------------|-------------------|
| **Chapter I (General Requirements)** | | |
| 1. Intended use | Compliant | [Ref] |
| 2. Risk-benefit | Compliant | [Ref] |
| 3. Safety and performance | Compliant | [Ref] |
| **Chapter II (Requirements for Design and Manufacture)** | | |
| 6.1 Chemical, physical and biological properties | Compliant | [Ref] |
| 6.2 Infection and microbial contamination | Compliant | [Ref] |
| 6.3 Properties for intended use | Compliant | [Ref] |
| 6.4 Interactions with environment | Compliant | [Ref] |
| 6.5 Software | Compliant | [Ref] |
| 6.6 Appliances with energy source | Compliant | [Ref] |
| 6.7 Information for user | Compliant | [Ref] |
| 6.8 Clinical evaluation | Compliant | [Ref] |
| 6.9 Post-market surveillance | Compliant | [Ref] |
| 6.10 General requirements for all devices | Compliant | [Ref] |
| 6.11 Devices for surgical invasion | Compliant | [Ref] |
| 6.12 Information for user (implantable) | Compliant | [Ref] |
| 6.13 Information supplied by manufacturer | Compliant | [Ref] |
| **Chapter III (Pre-clinical Testing)** | | |
| 7.1 Pre-clinical evaluation | Compliant | [Ref] |
| 7.2 Biological safety | Compliant | [Ref] |
| 7.3 Biocompatibility | Compliant | [Ref] |
| 7.4 Pre-clinical evaluation of groups | Compliant | [Ref] |
| **Chapter IV (Clinical Evaluation)** | | |
| 8. General requirements | Compliant | [Ref] |
| 8.1 Equivalence | Compliant | [Ref] |
| 8.2 Clinical investigation | Compliant | [Ref] |

---

### Section 4: Benefit-Risk Analysis

#### 4.1 Benefit Analysis

**Clinical Benefits**:

| Benefit | Evidence | Magnitude |
|---------|----------|-----------|
| [Benefit 1] | [Evidence reference] | [High/Medium/Low] |
| [Benefit 2] | [Evidence reference] | [High/Medium/Low] |

**Patient Benefits**: [Describe]

**Healthcare System Benefits**: [Describe]

#### 4.2 Risk Analysis

**Residual Risks**:

| Risk | Likelihood | Severity | Mitigation |
|------|------------|----------|------------|
| [Risk 1] | [High/Medium/Low] | [Serious/Moderate/Mild] | [Mitigation] |
| [Risk 2] | [High/Medium/Low] | [Serious/Moderate/Mild] | [Mitigation] |

**Risk Control Measures**: [Describe]

#### 4.3 Benefit-Risk Assessment

**Overall Benefit-Risk Profile**: [Favorable/Unfavorable]

**Rationale**: [Provide detailed justification]

**Comparison to Alternatives**: [Compare to available treatment options]

---

### Section 5: Clinical Evaluation

**Clinical Evaluation Report (CER)**: [Reference CER document TF-5.1]

**CER Summary**:

- Clinical evaluation methodology: [MEDDEV 2.7.1 rev 4]
- Data sources: [Literature, clinical investigation, PMS data]
- Clinical safety conclusion: [Demonstrated/Not demonstrated]
- Clinical performance conclusion: [Demonstrated/Not demonstrated]
- Overall conclusion: [CER conclusion]

**Clinical Investigation** (if applicable): [Reference clinical investigation report]

---

### Section 6: Post-Market Surveillance (PMS)

**PMS Plan**: [Reference PMS plan TF-6.1]

**PMS System Description**:

- PMS responsibilities: [Assigned personnel]
- PMS data sources: [Sources]
- PMS data collection methods: [Methods]
- PMS data analysis methods: [Methods]
- PMS reporting: [Reporting procedures]

**PMS Data Collection**:

| Data Type | Collection Method | Frequency |
|-----------|-------------------|-----------|
| Complaints | [Method] | Continuous |
| Adverse events | [Method] | Continuous |
| Field safety corrective actions | [Method] | As needed |
| Trends | [Method] | Periodic |
| Scientific literature | [Method] | Ongoing |

**PSUR** (Periodic Safety Update Report):

- PSUR frequency: [Annually/Every 2-3 years/Every 5 years]
- Last PSUR date: [Date]
- Next PSUR due: [Date]

---

### Section 7: Risk Management

**Risk Management Report**: [Reference risk management file TF-7.1]

**Risk Management Process**:

- Risk analysis performed: [Yes/No]
- Risk evaluation performed: [Yes/No]
- Risk control measures implemented: [Yes/No]
- Individual residual risks evaluated: [Yes/No]
- Overall residual risk evaluated: [Yes/No]
- Risk management review: [Frequency]

**Risk Summary**:

| Risk Category | Number of Risks | Mitigated | Acceptable |
|---------------|-----------------|-----------|------------|
| [Category 1] | [X] | [X] | [X] |
| [Category 2] | [X] | [X] | [X] |

---

### Section 8: Design Verification and Validation

#### 8.1 Design Verification

**Design Verification Plan**: [Reference]

**Verification Activities**:

| Design Feature | Verification Method | Acceptance Criteria | Result |
|----------------|---------------------|---------------------|--------|
| [Feature 1] | [Method] | [Criteria] | [Pass/Fail] |
| [Feature 2] | [Method] | [Criteria] | [Pass/Fail] |

#### 8.2 Design Validation

**Design Validation Plan**: [Reference]

**Validation Activities**:

| Requirement | Validation Method | Acceptance Criteria | Result |
|-------------|-------------------|---------------------|--------|
| [Requirement 1] | [Method] | [Criteria] | [Pass/Fail] |
| [Requirement 2] | [Method] | [Criteria] | [Pass/Fail] |

#### 8.3 Usability Engineering

**Usability Engineering File**: [Reference]

**Use Specification**:
- Intended user: [Describe]
- Intended use environment: [Describe]
- User interfaces: [Describe]

**Use-Related Risks**: [Reference to risk management]

**Validation of Usability**: [Reference validation report]

---

### Section 9: Manufacturing Processes

#### 9.1 Manufacturing Description

**Manufacturing Location(s)**: [List locations]

**Manufacturing Process Flow**: [Attach flow diagram]

**Critical Process Parameters**: [Identify and describe]

**Process Validation**: [Reference validation reports]

#### 9.2 Quality Management System

**QMS Certificate**: [ISO 13485 certificate number]

**QMS Scope**: [Scope of certification]

**Notified Body**: [NB number]

#### 9.3 Supplier Management

**Critical Suppliers**: [List]

**Supplier Controls**: [Describe supplier qualification and monitoring]

#### 9.4 Sterilization (if applicable)

**Sterilization Method**: [Method]

**Sterilization Validation**: [Reference validation report]

**Sterilization Cycle Parameters**:

| Parameter | Value | Tolerance |
|-----------|-------|-----------|
| [Parameter 1] | [Value] | [Tolerance] |
| [Parameter 2] | [Value] | [Tolerance] |

**Sterility Assurance Level (SAL)**: [10^-6 or 10^-3]

---

### Section 10: Biological Safety

**Biological Safety Evaluation**: [Reference TF-10.1]

**ISO 10993-1 Checklist**:

| ISO 10993 Test | Required? | Status | Reference |
|----------------|-----------|---------|-----------|
| Cytotoxicity | [Yes/No] | [Complete/Not required] | [Ref] |
| Sensitization | [Yes/No] | [Complete/Not required] | [Ref] |
| Irritation | [Yes/No] | [Complete/Not required] | [Ref] |
| Systemic toxicity | [Yes/No] | [Complete/Not required] | [Ref] |
| Genotoxicity | [Yes/No] | [Complete/Not required] | [Ref] |
| Implantation | [Yes/No] | [Complete/Not required] | [Ref] |
| Hemocompatibility | [Yes/No] | [Complete/Not required] | [Ref] |

**Chemical Characterization** (if applicable): [Reference report]

---

### Section 11: Biocompatibility (if applicable)

**Biocompatibility Report**: [Reference TF-11.1]

**Tissue Contact**: [Type and duration of contact]

**Biocompatibility Tests Performed**: [List tests and results]

---

### Section 12: Essential Principles Checklists

**Essential Principles Checklist**: [Attached]

**General Safety and Performance Requirements Compliance**: [Summary of compliance]

---

## Annex III: Technical Documentation for Class I Devices

**For Class I devices, the technical documentation shall include**:

- [ ] Device description and specifications
- [ ] Labelling and instructions for use
- [ ] General safety and performance requirements assessment
- [ ] Benefit-risk analysis
- [ ] Clinical evaluation report
- [ ] Post-market surveillance plan
- [ ] Risk management file
- [ ] Declaration of conformity

---

## Declaration of Conformity

**Declaration of Conformity Reference**: [DoC number]

**DoC Date**: [Date]

**Conformity Assessment Module**: [Module used]

---

## Signatures

| Role | Name | Signature | Date |
|------|------|-----------|------|
| **Prepared By** | | | |
| **Reviewed By** | | | |
| **Approved By** | | | |

---

**END OF TECHNICAL FILE TEMPLATE**

---

## Template Usage Notes

1. **Customization Instructions**:
   - Adapt for device class (I, IIa, IIb, III)
   - Add device-specific sections
   - Include all referenced documents

2. **Document Organization**:
   - Maintain document control for all referenced documents
   - Use consistent document numbering
   - Maintain traceability matrix

3. **Update Requirements**:
   - Update when device changes occur
   - Update when regulations change
   - Update as new data becomes available
